 | • レポートコード：MRC2-11QY08972 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は組換えヒトタンパク質のグローバル市場について調査・分析したレポートです。種類別（たんぱく質生産、たんぱく質精製）市場規模、用途別（研究所、医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別組換えヒトタンパク質の競争状況、市場シェア ・世界の組換えヒトタンパク質市場：種類別市場規模 2015年-2020年（たんぱく質生産、たんぱく質精製） ・世界の組換えヒトタンパク質市場：種類別市場規模予測 2021年-2026年（たんぱく質生産、たんぱく質精製） ・世界の組換えヒトタンパク質市場：用途別市場規模 2015年-2020年（研究所、医療） ・世界の組換えヒトタンパク質市場：用途別市場規模予測 2021年-2026年（研究所、医療） ・北米の組換えヒトタンパク質市場分析：米国、カナダ ・ヨーロッパの組換えヒトタンパク質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの組換えヒトタンパク質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の組換えヒトタンパク質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの組換えヒトタンパク質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Santa Cruz Biotechnology、OriGene、Cusabio、Amsbio、RayBiotech、Enzyme Research Laboratories、HYPHEN BIOMED ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Recombinant proteins are used throughout biological and biomedical science. Their production was once the domain of experts, but the development of simple, commercially available systems has made the technology more widespread.
Market Analysis and Insights: Global Recombinant Human Proteins Market
The global Recombinant Human Proteins market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Recombinant Human Proteins Scope and Market Size
Recombinant Human Proteins market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Recombinant Human Proteins market is segmented into
Protein Production
Protein Purification
Segment by Application, the Recombinant Human Proteins market is segmented into
Laboratories
Medical
Regional and Country-level Analysis
The Recombinant Human Proteins market is analysed and market size information is provided by regions (countries).
The key regions covered in the Recombinant Human Proteins market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Recombinant Human Proteins Market Share Analysis
Recombinant Human Proteins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Human Proteins business, the date to enter into the Recombinant Human Proteins market, Recombinant Human Proteins product introduction, recent developments, etc.
The major vendors covered:
Santa Cruz Biotechnology
OriGene
Cusabio
Amsbio
RayBiotech
Enzyme Research Laboratories
HYPHEN BIOMED
…
1 Study Coverage
1.1 Recombinant Human Proteins Product Introduction
1.2 Market Segments
1.3 Key Recombinant Human Proteins Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Human Proteins Market Size Growth Rate by Type
1.4.2 Protein Production
1.4.3 Protein Purification
1.5 Market by Application
1.5.1 Global Recombinant Human Proteins Market Size Growth Rate by Application
1.5.2 Laboratories
1.5.3 Medical
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Proteins Market Size, Estimates and Forecasts
2.1.1 Global Recombinant Human Proteins Revenue 2015-2026
2.1.2 Global Recombinant Human Proteins Sales 2015-2026
2.2 Global Recombinant Human Proteins, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Recombinant Human Proteins Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Human Proteins Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Recombinant Human Proteins Competitor Landscape by Players
3.1 Recombinant Human Proteins Sales by Manufacturers
3.1.1 Recombinant Human Proteins Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Human Proteins Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Human Proteins Revenue by Manufacturers
3.2.1 Recombinant Human Proteins Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Human Proteins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Human Proteins Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Human Proteins Revenue in 2019
3.2.5 Global Recombinant Human Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Human Proteins Price by Manufacturers
3.4 Recombinant Human Proteins Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Proteins Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Proteins Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Proteins Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Recombinant Human Proteins Market Size by Type (2015-2020)
4.1.1 Global Recombinant Human Proteins Sales by Type (2015-2020)
4.1.2 Global Recombinant Human Proteins Revenue by Type (2015-2020)
4.1.3 Recombinant Human Proteins Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Human Proteins Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Human Proteins Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Proteins Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Human Proteins Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Human Proteins Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Recombinant Human Proteins Market Size by Application (2015-2020)
5.1.1 Global Recombinant Human Proteins Sales by Application (2015-2020)
5.1.2 Global Recombinant Human Proteins Revenue by Application (2015-2020)
5.1.3 Recombinant Human Proteins Price by Application (2015-2020)
5.2 Recombinant Human Proteins Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Human Proteins Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Proteins Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Proteins Price Forecast by Application (2021-2026)
6 North America
6.1 North America Recombinant Human Proteins by Country
6.1.1 North America Recombinant Human Proteins Sales by Country
6.1.2 North America Recombinant Human Proteins Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Human Proteins Market Facts & Figures by Type
6.3 North America Recombinant Human Proteins Market Facts & Figures by Application
7 Europe
7.1 Europe Recombinant Human Proteins by Country
7.1.1 Europe Recombinant Human Proteins Sales by Country
7.1.2 Europe Recombinant Human Proteins Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Proteins Market Facts & Figures by Type
7.3 Europe Recombinant Human Proteins Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Human Proteins by Region
8.1.1 Asia Pacific Recombinant Human Proteins Sales by Region
8.1.2 Asia Pacific Recombinant Human Proteins Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Human Proteins Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Human Proteins Market Facts & Figures by Application
9 Latin America
9.1 Latin America Recombinant Human Proteins by Country
9.1.1 Latin America Recombinant Human Proteins Sales by Country
9.1.2 Latin America Recombinant Human Proteins Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Human Proteins Market Facts & Figures by Type
9.3 Central & South America Recombinant Human Proteins Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Proteins by Country
10.1.1 Middle East and Africa Recombinant Human Proteins Sales by Country
10.1.2 Middle East and Africa Recombinant Human Proteins Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Human Proteins Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Human Proteins Market Facts & Figures by Application
11 Company Profiles
11.1 Santa Cruz Biotechnology
11.1.1 Santa Cruz Biotechnology Corporation Information
11.1.2 Santa Cruz Biotechnology Description and Business Overview
11.1.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santa Cruz Biotechnology Recombinant Human Proteins Products Offered
11.1.5 Santa Cruz Biotechnology Related Developments
11.2 OriGene
11.2.1 OriGene Corporation Information
11.2.2 OriGene Description and Business Overview
11.2.3 OriGene Sales, Revenue and Gross Margin (2015-2020)
11.2.4 OriGene Recombinant Human Proteins Products Offered
11.2.5 OriGene Related Developments
11.3 Cusabio
11.3.1 Cusabio Corporation Information
11.3.2 Cusabio Description and Business Overview
11.3.3 Cusabio Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cusabio Recombinant Human Proteins Products Offered
11.3.5 Cusabio Related Developments
11.4 Amsbio
11.4.1 Amsbio Corporation Information
11.4.2 Amsbio Description and Business Overview
11.4.3 Amsbio Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amsbio Recombinant Human Proteins Products Offered
11.4.5 Amsbio Related Developments
11.5 RayBiotech
11.5.1 RayBiotech Corporation Information
11.5.2 RayBiotech Description and Business Overview
11.5.3 RayBiotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 RayBiotech Recombinant Human Proteins Products Offered
11.5.5 RayBiotech Related Developments
11.6 Enzyme Research Laboratories
11.6.1 Enzyme Research Laboratories Corporation Information
11.6.2 Enzyme Research Laboratories Description and Business Overview
11.6.3 Enzyme Research Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Enzyme Research Laboratories Recombinant Human Proteins Products Offered
11.6.5 Enzyme Research Laboratories Related Developments
11.7 HYPHEN BIOMED
11.7.1 HYPHEN BIOMED Corporation Information
11.7.2 HYPHEN BIOMED Description and Business Overview
11.7.3 HYPHEN BIOMED Sales, Revenue and Gross Margin (2015-2020)
11.7.4 HYPHEN BIOMED Recombinant Human Proteins Products Offered
11.7.5 HYPHEN BIOMED Related Developments
11.1 Santa Cruz Biotechnology
11.1.1 Santa Cruz Biotechnology Corporation Information
11.1.2 Santa Cruz Biotechnology Description and Business Overview
11.1.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santa Cruz Biotechnology Recombinant Human Proteins Products Offered
11.1.5 Santa Cruz Biotechnology Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Recombinant Human Proteins Market Estimates and Projections by Region
12.1.1 Global Recombinant Human Proteins Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Human Proteins Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Human Proteins Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Human Proteins Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Human Proteins Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Human Proteins Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Human Proteins Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Human Proteins Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Human Proteins Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Human Proteins Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Human Proteins Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Human Proteins Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Human Proteins Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Human Proteins Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Human Proteins Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Human Proteins Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Human Proteins Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Human Proteins Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Human Proteins Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Human Proteins Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Human Proteins Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Human Proteins Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Human Proteins Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Human Proteins Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Recombinant Human Proteins Market Segments
Table 2. Ranking of Global Top Recombinant Human Proteins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Human Proteins Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Protein Production
Table 5. Major Manufacturers of Protein Purification
Table 6. Global Recombinant Human Proteins Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Recombinant Human Proteins Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Recombinant Human Proteins Sales by Regions 2015-2020 (K Units)
Table 9. Global Recombinant Human Proteins Sales Market Share by Regions (2015-2020)
Table 10. Global Recombinant Human Proteins Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Recombinant Human Proteins Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Recombinant Human Proteins Sales Share by Manufacturers (2015-2020)
Table 13. Global Recombinant Human Proteins Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Recombinant Human Proteins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Proteins as of 2019)
Table 15. Recombinant Human Proteins Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Recombinant Human Proteins Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Recombinant Human Proteins Price (2015-2020) (USD/Unit)
Table 18. Recombinant Human Proteins Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Recombinant Human Proteins Product Type
Table 20. Date of International Manufacturers Enter into Recombinant Human Proteins Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Recombinant Human Proteins Sales by Type (2015-2020) (K Units)
Table 23. Global Recombinant Human Proteins Sales Share by Type (2015-2020)
Table 24. Global Recombinant Human Proteins Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Recombinant Human Proteins Revenue Share by Type (2015-2020)
Table 26. Recombinant Human Proteins Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Recombinant Human Proteins Sales by Application (2015-2020) (K Units)
Table 28. Global Recombinant Human Proteins Sales Share by Application (2015-2020)
Table 29. North America Recombinant Human Proteins Sales by Country (2015-2020) (K Units)
Table 30. North America Recombinant Human Proteins Sales Market Share by Country (2015-2020)
Table 31. North America Recombinant Human Proteins Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Recombinant Human Proteins Revenue Market Share by Country (2015-2020)
Table 33. North America Recombinant Human Proteins Sales by Type (2015-2020) (K Units)
Table 34. North America Recombinant Human Proteins Sales Market Share by Type (2015-2020)
Table 35. North America Recombinant Human Proteins Sales by Application (2015-2020) (K Units)
Table 36. North America Recombinant Human Proteins Sales Market Share by Application (2015-2020)
Table 37. Europe Recombinant Human Proteins Sales by Country (2015-2020) (K Units)
Table 38. Europe Recombinant Human Proteins Sales Market Share by Country (2015-2020)
Table 39. Europe Recombinant Human Proteins Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Recombinant Human Proteins Revenue Market Share by Country (2015-2020)
Table 41. Europe Recombinant Human Proteins Sales by Type (2015-2020) (K Units)
Table 42. Europe Recombinant Human Proteins Sales Market Share by Type (2015-2020)
Table 43. Europe Recombinant Human Proteins Sales by Application (2015-2020) (K Units)
Table 44. Europe Recombinant Human Proteins Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Recombinant Human Proteins Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Recombinant Human Proteins Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Recombinant Human Proteins Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Recombinant Human Proteins Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Recombinant Human Proteins Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Recombinant Human Proteins Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Recombinant Human Proteins Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Recombinant Human Proteins Sales Market Share by Application (2015-2020)
Table 53. Latin America Recombinant Human Proteins Sales by Country (2015-2020) (K Units)
Table 54. Latin America Recombinant Human Proteins Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Recombinant Human Proteins Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Recombinant Human Proteins Revenue Market Share by Country (2015-2020)
Table 57. Latin America Recombinant Human Proteins Sales by Type (2015-2020) (K Units)
Table 58. Latin America Recombinant Human Proteins Sales Market Share by Type (2015-2020)
Table 59. Latin America Recombinant Human Proteins Sales by Application (2015-2020) (K Units)
Table 60. Latin America Recombinant Human Proteins Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Recombinant Human Proteins Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Recombinant Human Proteins Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Recombinant Human Proteins Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Recombinant Human Proteins Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Recombinant Human Proteins Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Recombinant Human Proteins Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Recombinant Human Proteins Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Recombinant Human Proteins Sales Market Share by Application (2015-2020)
Table 69. Santa Cruz Biotechnology Corporation Information
Table 70. Santa Cruz Biotechnology Description and Major Businesses
Table 71. Santa Cruz Biotechnology Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Santa Cruz Biotechnology Product
Table 73. Santa Cruz Biotechnology Recent Development
Table 74. OriGene Corporation Information
Table 75. OriGene Description and Major Businesses
Table 76. OriGene Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. OriGene Product
Table 78. OriGene Recent Development
Table 79. Cusabio Corporation Information
Table 80. Cusabio Description and Major Businesses
Table 81. Cusabio Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Cusabio Product
Table 83. Cusabio Recent Development
Table 84. Amsbio Corporation Information
Table 85. Amsbio Description and Major Businesses
Table 86. Amsbio Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Amsbio Product
Table 88. Amsbio Recent Development
Table 89. RayBiotech Corporation Information
Table 90. RayBiotech Description and Major Businesses
Table 91. RayBiotech Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. RayBiotech Product
Table 93. RayBiotech Recent Development
Table 94. Enzyme Research Laboratories Corporation Information
Table 95. Enzyme Research Laboratories Description and Major Businesses
Table 96. Enzyme Research Laboratories Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Enzyme Research Laboratories Product
Table 98. Enzyme Research Laboratories Recent Development
Table 99. HYPHEN BIOMED Corporation Information
Table 100. HYPHEN BIOMED Description and Major Businesses
Table 101. HYPHEN BIOMED Recombinant Human Proteins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. HYPHEN BIOMED Product
Table 103. HYPHEN BIOMED Recent Development
Table 104. Global Recombinant Human Proteins Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Recombinant Human Proteins Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Recombinant Human Proteins Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Recombinant Human Proteins Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Recombinant Human Proteins Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Recombinant Human Proteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Recombinant Human Proteins Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Recombinant Human Proteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Recombinant Human Proteins Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Recombinant Human Proteins Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Recombinant Human Proteins Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Recombinant Human Proteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Recombinant Human Proteins Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Recombinant Human Proteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Recombinant Human Proteins Players
Table 122. Recombinant Human Proteins Customers List
Table 123. Recombinant Human Proteins Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Proteins Product Picture
Figure 2. Global Recombinant Human Proteins Sales Market Share by Type in 2020 & 2026
Figure 3. Protein Production Product Picture
Figure 4. Protein Purification Product Picture
Figure 5. Global Recombinant Human Proteins Sales Market Share by Application in 2020 & 2026
Figure 6. Laboratories
Figure 7. Medical
Figure 8. Recombinant Human Proteins Report Years Considered
Figure 9. Global Recombinant Human Proteins Market Size 2015-2026 (US$ Million)
Figure 10. Global Recombinant Human Proteins Sales 2015-2026 (K Units)
Figure 11. Global Recombinant Human Proteins Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Recombinant Human Proteins Sales Market Share by Region (2015-2020)
Figure 13. Global Recombinant Human Proteins Sales Market Share by Region in 2019
Figure 14. Global Recombinant Human Proteins Revenue Market Share by Region (2015-2020)
Figure 15. Global Recombinant Human Proteins Revenue Market Share by Region in 2019
Figure 16. Global Recombinant Human Proteins Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human Proteins Revenue in 2019
Figure 18. Recombinant Human Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Recombinant Human Proteins Sales Market Share by Type (2015-2020)
Figure 20. Global Recombinant Human Proteins Sales Market Share by Type in 2019
Figure 21. Global Recombinant Human Proteins Revenue Market Share by Type (2015-2020)
Figure 22. Global Recombinant Human Proteins Revenue Market Share by Type in 2019
Figure 23. Global Recombinant Human Proteins Market Share by Price Range (2015-2020)
Figure 24. Global Recombinant Human Proteins Sales Market Share by Application (2015-2020)
Figure 25. Global Recombinant Human Proteins Sales Market Share by Application in 2019
Figure 26. Global Recombinant Human Proteins Revenue Market Share by Application (2015-2020)
Figure 27. Global Recombinant Human Proteins Revenue Market Share by Application in 2019
Figure 28. North America Recombinant Human Proteins Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Recombinant Human Proteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Recombinant Human Proteins Sales Market Share by Country in 2019
Figure 31. North America Recombinant Human Proteins Revenue Market Share by Country in 2019
Figure 32. U.S. Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Recombinant Human Proteins Market Share by Type in 2019
Figure 37. North America Recombinant Human Proteins Market Share by Application in 2019
Figure 38. Europe Recombinant Human Proteins Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Recombinant Human Proteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Recombinant Human Proteins Sales Market Share by Country in 2019
Figure 41. Europe Recombinant Human Proteins Revenue Market Share by Country in 2019
Figure 42. Germany Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Recombinant Human Proteins Market Share by Type in 2019
Figure 53. Europe Recombinant Human Proteins Market Share by Application in 2019
Figure 54. Asia Pacific Recombinant Human Proteins Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Recombinant Human Proteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Recombinant Human Proteins Sales Market Share by Region in 2019
Figure 57. Asia Pacific Recombinant Human Proteins Revenue Market Share by Region in 2019
Figure 58. China Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Recombinant Human Proteins Market Share by Type in 2019
Figure 81. Asia Pacific Recombinant Human Proteins Market Share by Application in 2019
Figure 82. Latin America Recombinant Human Proteins Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Recombinant Human Proteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Recombinant Human Proteins Sales Market Share by Country in 2019
Figure 85. Latin America Recombinant Human Proteins Revenue Market Share by Country in 2019
Figure 86. Mexico Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Recombinant Human Proteins Market Share by Type in 2019
Figure 93. Latin America Recombinant Human Proteins Market Share by Application in 2019
Figure 94. Middle East and Africa Recombinant Human Proteins Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Recombinant Human Proteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Recombinant Human Proteins Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Recombinant Human Proteins Revenue Market Share by Country in 2019
Figure 98. Turkey Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Recombinant Human Proteins Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Recombinant Human Proteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Recombinant Human Proteins Market Share by Type in 2019
Figure 105. Middle East and Africa Recombinant Human Proteins Market Share by Application in 2019
Figure 106. North America Recombinant Human Proteins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Recombinant Human Proteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Recombinant Human Proteins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Recombinant Human Proteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Recombinant Human Proteins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Recombinant Human Proteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Recombinant Human Proteins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Recombinant Human Proteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Recombinant Human Proteins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Recombinant Human Proteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…
- 組換えタンパク質の世界市場（～2026年） Market Analysis and Insights: Global Recombinant Protein Market The global Recombinant Protein market size is projected to reach US$ 665.5 million by 2026, from US$ 612 million in 2020, at a CAGR of 8.1%% during 2021-2026. Global Recombinant Protein Scope and Market Size Recombinant Protein market i…
- 組換え凝固因子の世界市場（～2026年） Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Market Analysis and Insights: Global Recomb…
- ヒトパピローマウイルスタンパク質E6の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus Protein E6 Market The global Human Papillomavirus Protein E6 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus Protein E6 Scope and Market Si…